<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>107(4)</volume><submitter>Ager EI</submitter><pubmed_abstract>Matrix metalloproteinase (MMP) 14 may mediate tumor progression through vascular and immune-modulatory effects. Orthotopic murine breast tumors (4T1 and E0771 with high and low MMP14 expression, respectively; n = 5-10 per group) were treated with an anti-MMP14 inhibitory antibody (DX-2400), IgG control, fractionated radiation therapy, or their combination. We assessed primary tumor growth, transforming growth factor β (TGFβ) and inducible nitric oxide synthase (iNOS) expression, macrophage phenotype, and vascular parameters. A linear mixed model with repeated observations, with Mann-Whitney or analysis of variance with Bonferroni post hoc adjustment, was used to determine statistical significance. All statistical tests were two-sided. DX-2400 inhibited tumor growth compared with IgG contro</pubmed_abstract><journal>Journal of the National Cancer Institute</journal><pagination>djv017</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4402365</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy.</pubmed_title><pmcid>PMC4402365</pmcid><pubmed_authors>Askoxylakis V</pubmed_authors><pubmed_authors>Devy L</pubmed_authors><pubmed_authors>Ager EI</pubmed_authors><pubmed_authors>Boucher Y</pubmed_authors><pubmed_authors>Kodack DP</pubmed_authors><pubmed_authors>Fukumura D</pubmed_authors><pubmed_authors>Jain RK</pubmed_authors><pubmed_authors>Goel S</pubmed_authors><pubmed_authors>Snuderl M</pubmed_authors><pubmed_authors>Kirkpatrick ND</pubmed_authors><pubmed_authors>Finkelstein DM</pubmed_authors><pubmed_authors>Dransfield DT</pubmed_authors><pubmed_authors>Huang Y</pubmed_authors><pubmed_authors>Kozin SV</pubmed_authors><pubmed_authors>Muzikansky A</pubmed_authors><pubmed_authors>Seano G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy.</name><description>Matrix metalloproteinase (MMP) 14 may mediate tumor progression through vascular and immune-modulatory effects. Orthotopic murine breast tumors (4T1 and E0771 with high and low MMP14 expression, respectively; n = 5-10 per group) were treated with an anti-MMP14 inhibitory antibody (DX-2400), IgG control, fractionated radiation therapy, or their combination. We assessed primary tumor growth, transforming growth factor β (TGFβ) and inducible nitric oxide synthase (iNOS) expression, macrophage phenotype, and vascular parameters. A linear mixed model with repeated observations, with Mann-Whitney or analysis of variance with Bonferroni post hoc adjustment, was used to determine statistical significance. All statistical tests were two-sided. DX-2400 inhibited tumor growth compared with IgG contro</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Apr</publication><modification>2025-04-19T00:47:57.67Z</modification><creation>2019-03-27T01:50:07Z</creation></dates><accession>S-EPMC4402365</accession><cross_references><pubmed>25710962</pubmed><doi>10.1093/jnci/djv017</doi></cross_references></HashMap>